Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Thirant, Cécile ^a   Bessette, Barbara ^a   Varlet, Pascale ^a,b   Puget, Stéphanie ^c,d   Cadusseau, Josette ^e   Tavares, Silvina dos Reis ^a   Studler, Jeanne Marie ^a,f   Silvestre, David Carlos ^a   Susini, Aurélie ^g   Villa, Chiara ^a,b   Miquel, Catherine ^a,b   Bogeas, Alexandra ^a   Surena, Anne Laure ^a   Dias Morais, Amélia ^a   Léonard, Nadine ^a,b   Pflumio, Françoise ^a   Biéche, Ivan ^g   Boussin, François D ^a   Sainte Rose, Christian ^c   Grill, Jacques ^d   Daumas Duport, Catherine ^a,b   Chneiweiss, Hervé ^a   Junier, Marie Pierre ^a,b   more..

^a INSERM   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^f l'alimentation et l'Environnement   (France)

^g INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RESISTANCE; CANCER SURVIVAL; CELL ACTIVITY; CELL ISOLATION; CELL RENEWAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CYTOLOGY; DISEASE ACTIVITY; EMBRYONIC STEM CELL; EPENDYMOMA; FEMALE; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MESENCHYME CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; BRAIN TUMOR; CANCER STEM CELL; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOPHENOTYPING; INFANT; PATHOLOGY; PRESCHOOL CHILD; SURVIVAL;

ADOLESCENT; BRAIN NEOPLASMS; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GLIOMA; HUMANS; IMMUNOPHENOTYPING; INFANT; MALE; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; SURVIVAL ANALYSIS;

EID: 79551515438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016375     Document Type: Article

References (59)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
2. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, et al. (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113: 1953-1968.
3. Park DM, Rich JN (2009) Biology of glioma cancer stem cells. Mol Cells 28: 7-12.
4. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
5. Nakai E, Park K, Yawata T, Chihara T, Kumazawa A, et al. (2009) Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from Glioblastoma. Cancer Invest 27: 901-908.
6. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, et al. (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39: 193-206.
7. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
8. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Henkelman, M.D. Cusimano, P.B. Dirks, Identification of human brain tumour initiating cells. Nature 432: 396-401.
9. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, et al. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human Glioblastoma. Cancer Res 64: 7011-7021.
10. Varlet P, Soni D, Miquel C, Roux FX, Meder JF, et al. (2004) New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases. Neurosurgery 55: 1377-1391: discussion 1391-1372.
11. Patru C, Romao L, Varlet P, Coulombel L, Raponi E, et al. (2010) CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glioneuronal tumors. BMC Cancer 10: 66.
12. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, et al. (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100: 15178-15183.
13. Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, et al. (2009) Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 27: 980-987.
14. Louis SA, Rietze RL, Deleyrolle L, Wagey RE, Thomas TE, et al. (2008) Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay. Stem Cells 26: 988-996.
15. Vescovi AL, Gritti A, Galli R, Parati EA (1999) Isolation and intracerebral grafting of nontransformed multipotential embryonic human CNS stem cells. J Neurotrauma 16: 689-693.
16. Grimmer MR, Weiss WA (2006) Childhood tumors of the nervous system as disorders of normal development. Curr Opin Pediatr 18: 634-638.
17. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, et al. (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23: 9392-9400.
18. Dufour C, Cadusseau J, Varlet P, Surena AL, de Faria GP, et al. (2009) Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation. Stem Cells 27: 2373-2382.
19. Dai C, Holland EC (2003) Astrocyte differentiation states and glioma formation. Cancer J 9: 72-81.
20. Sutter R, Yadirgi G, Marino S (2007) Neural stem cells, tumour stem cells and brain tumours: dangerous relationships? Biochim Biophys Acta 1776: 125-137.
21. Kalifa C, Grill J (2005) The therapy of infantile malignant brain tumors: current status? J Neurooncol 75: 279-285.
22. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, et al. (2007) Molecular pathogenesis of pediatric astrocytic tumors. Neuro Oncol 9: 113-123.
23. Bredel M, Pollack IF, Hamilton RL, James CD (1999) Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood. Clin Cancer Res 5: 1786-1792.
24. Bax DA, Little SE, Gaspar N, Perryman L, Marshall L, et al. (2009) Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development. PLoS One 4: e5209.
25. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, et al. (2005) Radial glia cells are candidate stem cells of Ependymoma. Cancer Cell 8: 323-335.
26. Platet N, Liu SY, Atifi ME, Oliver L, Vallette FM, et al. (2007) Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett 258: 286-290.
27. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, et al. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015.
28. Wang J, Sakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, et al. (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122: 761-768.
29. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317: 337.
30. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
31. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, et al. (2010) A hierarchy of self-renewing tumor-initiating cell types in glioblastoma, Cancer Cell 17: 362-375.
32. Gritti A, Galli R, Vescovi AL (2001) Cultures of stem cells of the central nervous system. In: Fedoroff S, Richarson A, editors. Protocols for neural cell culture. Humana Press. pp173-198.
33. Sharif A, Renault F, Beuvon F, Castellanos R, Canton B, et al. (2004) The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience 126: 263-275.
34. Bieche I, Parfait B, Laurendeau I, Girault I, Vidaud M, et al. (2001) Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene 20: 8109-8115.
35. Varlet P, Jouvet A, Miquel C, Saint-Pierre G, Beuvon F, et al. (2005) Criteria of diagnosis and grading of oligodendrogliomas or oligo-astrocytomas according to the WHO and Sainte-Anne classifications. Neurochirurgie 51: 239-246.
36. Kelley TW, Tubbs RR, Prayson RA (2005) Molecular diagnostic techniques for the clinical evaluation of gliomas. Diagn Mol Pathol 14: 1-8.
37. Sung T, Miller DC, Hayes RL, Alonso M, Yee H, et al. (2000) Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Pathol 10: 249-259.
38. Barraud P, Stott S, Mollgard K, Parmar M, Bjorklund A (2007) In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133. J Neurosci Res 85: 250-259.
39. Park IK, Morrison SJ, Clarke MF (2004) Bmi1, stem cells, and senescence regulation. J Clin Invest 113: 175-179.
40. Nicolis SK (2007) Cancer stem cells and stemness genes in neuro-oncology. Neurobiol Dis 25: 217-229.
41. Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6: 425-436.
42. Kageyama R, Ishibashi M, Takebayashi K, Tomita K (1997) bHLH transcription factors and mammalian neuronal differentiation. Int J Biochem Cell Biol 29: 1389-1399.
43. Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, et al. (2003) Transient expression of doublecortin during adult neurogenesis. J Comp Neurol 467: 1-10.
44. Liu Y, Han SS, Wu Y, Tuohy TM, Xue H, et al. (2004) CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol 276: 31-46.
45. Xu Y, Stamenkovic I, Yu Q (2010) CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for Glioblastoma. Cancer Res 70: 2455-2464.
46. Hu BY, Du ZW, Zhang SC (2009) Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 4: 1614-1622.
47. Katsetos CD, Draberova E, Legido A, Draber P (2009) Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin. J Cell Physiol 221: 514-520.
48. Middeldorp J, Boer K, Sluijs JA, De Filippis L, Encha-Razavi F, et al. (2010) GFAPdelta in radial glia and subventricular zone progenitors in the developing human cortex. Development 137: 313-321.
49. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325.
50. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
51. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, et al. (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations, PLoS One 4: e7752.
52. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, Cancer Cell 9: 157-173.
53. Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, et al. (2009) Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol 94: 1-19.
54. Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, et al. (2008) Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria, Oncogene 27: 2897-2909.
55. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, et al. (2008) Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14: 8205-8212.
56. Panosyan EH, Laks DR, Masterman-Smith M, Mottahedeh J, Yong WH, et al. (2010) Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation. Pediatr Blood Cancer 55: 644-651.
57. Kondo T, Raff M (2000) Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289: 1754-1757.
58. Real C, Glavieux-Pardanaud C, Le Douarin NM, Dupin E (2006) Clonally cultured differentiated pigment cells can dedifferentiate and generate multipotent progenitors with self-renewing potential. Dev Biol 300: 656-669.
59. Sharif A, Legendre P, Prevot V, Allet C, Romao L (2007) Transforming growth factor alpha promotes sequential conversion of mature astrocytes into neural progenitors and stem cells. Oncogene 26: 2695-2706.